The Chemotherapy Board provides guidance, oversight and support for the continuing development of chemotherapy services in the UK.
The UK Chemotherapy Board was established in 2013 by The Royal College of Radiologists (RCR), the Royal College of Physicians (RCP), the Association of Cancer Physicians (ACP), the Royal College of Pathologists (RCPath), the British Oncology Pharmacy Association (BOPA) and the UK Oncology Nursing Society (UKONS). The Board has representation from across the four UK nations and from other organisations closely involved in SACT services.
The UK SACT (Systemic Anti-Cancer Therapy) Board provides guidance, oversight and support for the continuing development of SACT services in the UK.
Netty Cracknell
Co-Chair
Netty Cracknell
Netty has over 20 years’ experience as a specialist oncology pharmacist working in both government and private organisations within the UK. She is currently Principal Pharmacist – Operations, for Genesis Care UK. Netty is President of The International Society of Oncology Pharmacy Practitioners (ISOPP) and co-chair of the UK SACT Board. Netty has previously held various leadership positions within the British Oncology Pharmacy Association (BOPA) and has independently led several National and International Projects. Netty was announced a Fellow of the Royal Pharmaceutical Society in 2022 and a Fellow of BOPA in 2023.
Netty is passionate about improving cancer care globally and improving safety for patients and staff through the use of digital media. Netty also has a keen interest in education and training and uses her strengths to support all pharmacy staff in all sectors and countries to improve access to learning globally.
Joseph Williams
Co-Chair
Joseph Williams
Joseph is a Specialist Cancer Pharmacist at The Christie NHS Foundation Trust with a specialist clinical and research interest in colorectal cancer and care closer to home. He is also an independent prescriber within the colorectal cancer speciality. Joseph is an Honorary Clinical Lecturer in the Division of Pharmacy & Optometry at the University of Manchester (UoM) where he teaches on the Cancer programme for Undergraduates and Postgraduates. His background has vastly been in clinical practice and his patient facing role within the MDT has allowed him to initiate and progress applied health research projects in his area of practice to benefit patient care. His experience and accolades have allowed Joseph to be elected as Chair of the British Oncology Pharmacy Association (BOPA), elected as a member of the UK SACT Board, become a member of the UK Pharmacy Professional Leadership (PPL) Advisory Board and a Fellow of the Royal Pharmaceutical Society (RPS). Joseph is passionate about promoting excellence in pharmaceutical care of patients with cancer through education, research, and innovation.
Specialist Advisory Groups
There are several specialist interest groups with BOPA. The groups and BOPA work together jointly to promote excellence in the pharmaceutical care of patients with cancer through education, communication, research or innovation.
There are several subcommittees & working groups that report directly to the Executive Committee each month. These subcommittees & working groups support the executive committee and keep the organisation at the forefront of care.
The Executive Committee work on behalf of the BOPA members to prioritise and co-ordinate the many activities and workstreams required to achieve our goals
Our website uses cookies to distinguish you from other users of our website. This helps us to provide you with a good experience when you browse our website and also allows us to improve our site. By continuing to browse the site, you are agreeing to our use of cookies.
